Therefore, MMPP exhibits promising therapeutic potential by simultaneously targeting two pivotal signaling pathways involved in ADPKD, namely oxidative stress and cAMP-CREB (Fig. 7). The gene discussed is CREB1; the disease is autosomal dominant polycystic kidney disease.